These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20848663)

  • 21. Tumorigenic and metastatic activity of human thyroid cancer stem cells.
    Todaro M; Iovino F; Eterno V; Cammareri P; Gambara G; Espina V; Gulotta G; Dieli F; Giordano S; De Maria R; Stassi G
    Cancer Res; 2010 Nov; 70(21):8874-85. PubMed ID: 20959469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures.
    Zhou L; Jiang Y; Yan T; Di G; Shen Z; Shao Z; Lu J
    Breast Cancer Res Treat; 2010 Aug; 122(3):795-801. PubMed ID: 20571867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldehyde dehydrogenases and cancer stem cells.
    Xu X; Chai S; Wang P; Zhang C; Yang Y; Yang Y; Wang K
    Cancer Lett; 2015 Dec; 369(1):50-7. PubMed ID: 26319899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended passaging, but not aldehyde dehydrogenase activity, increases the chondrogenic potential of human adipose-derived adult stem cells.
    Estes BT; Wu AW; Storms RW; Guilak F
    J Cell Physiol; 2006 Dec; 209(3):987-95. PubMed ID: 16972251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells.
    Doherty RE; Haywood-Small SL; Sisley K; Cross NA
    Biochem Biophys Res Commun; 2011 Nov; 414(4):801-7. PubMed ID: 22005464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.
    Resetkova E; Reis-Filho JS; Jain RK; Mehta R; Thorat MA; Nakshatri H; Badve S
    Breast Cancer Res Treat; 2010 Aug; 123(1):97-108. PubMed ID: 19911270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis.
    Hemmings C
    Pathology; 2010 Feb; 42(2):105-12. PubMed ID: 20085510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Kit expression in human normal and malignant stem cells prognostic and therapeutic implications.
    Hassan HT
    Leuk Res; 2009 Jan; 33(1):5-10. PubMed ID: 18639336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of stem and circulating cells in cancer metastasis.
    Ghadially R
    J Surg Oncol; 2011 May; 103(6):555-7. PubMed ID: 21480249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alcohol dehydrogenase and aldehyde dehydrogenase as tumour markers and factors intensifying carcinogenesis in colorectal cancer].
    Jelski W; Orywal K; Kedra B; Szmitkowski M
    Pol Merkur Lekarski; 2008 Jun; 24(144):506-10. PubMed ID: 18702331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-renewal and solid tumor stem cells.
    Al-Hajj M; Clarke MF
    Oncogene; 2004 Sep; 23(43):7274-82. PubMed ID: 15378087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is ALDH1 a good method for definition of breast cancer stem cells?
    Neumeister V; Rimm D
    Breast Cancer Res Treat; 2010 Aug; 123(1):109-11. PubMed ID: 19946740
    [No Abstract]   [Full Text] [Related]  

  • 33. Aldehyde dehydrogenase as a marker for stem cells.
    Moreb JS
    Curr Stem Cell Res Ther; 2008 Dec; 3(4):237-46. PubMed ID: 19075754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors.
    Rodriguez-Torres M; Allan AL
    Clin Exp Metastasis; 2016 Jan; 33(1):97-113. PubMed ID: 26445849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The cancer stem cell: the breast cancer driver].
    Ginestier C; Korkaya H; Dontu G; Birnbaum D; Wicha MS; Charafe-Jauffret E
    Med Sci (Paris); 2007 Dec; 23(12):1133-9. PubMed ID: 18154716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay.
    Zhou L; Sheng D; Wang D; Ma W; Deng Q; Deng L; Liu S
    Cell Biol Toxicol; 2019 Apr; 35(2):161-177. PubMed ID: 30220009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor initiating cancer stem cells from human breast cancer cell lines.
    Han JS; Crowe DL
    Int J Oncol; 2009 May; 34(5):1449-53. PubMed ID: 19360358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer.
    Nakamura M; Kyo S; Zhang B; Zhang X; Mizumoto Y; Takakura M; Maida Y; Mori N; Hashimoto M; Ohno S; Inoue M
    Hum Pathol; 2010 Nov; 41(11):1516-29. PubMed ID: 20800872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow-derived aldehyde dehydrogenase-bright stem and progenitor cells for ischemic repair.
    Keller LH
    Congest Heart Fail; 2009; 15(4):202-6. PubMed ID: 19627297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide.
    Sreerama L; Sladek NE
    Drug Metab Dispos; 1995 Oct; 23(10):1080-4. PubMed ID: 8654195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.